These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32750605)

  • 1. Catechol-modified chitosan/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells.
    Pornpitchanarong C; Rojanarata T; Opanasopit P; Ngawhirunpat T; Patrojanasophon P
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111279. PubMed ID: 32750605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol-Functionalized Alginate Nanoparticles as Mucoadhesive Carriers for Intravesical Chemotherapy.
    Sahatsapan N; Ngawhirunpat T; Rojanarata T; Opanasopit P; Patrojanasophon P
    AAPS PharmSciTech; 2020 Jul; 21(6):212. PubMed ID: 32737610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
    Salehi Khesht AM; Karpisheh V; Sahami Gilan P; Melnikova LA; Olegovna Zekiy A; Mohammadi M; Hojjat-Farsangi M; Majidi Zolbanin N; Mahmoodpoor A; Hassannia H; Aghebati-Maleki L; Jafari R; Jadidi-Niaragh F
    Int J Biol Macromol; 2021 Sep; 186():849-863. PubMed ID: 34245737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan functionalized doxorubicin loaded poly(methacrylamide) based copolymeric nanoparticles for enhanced cellular internalization and in vitro anticancer evaluation.
    Manhas P; Cokca C; Sharma R; Peneva K; Wangoo N; Sharma D; Sharma RK
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129242. PubMed ID: 38199540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
    Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
    Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    El-Ghareb WI; Swidan MM; Ibrahim IT; Abd El-Bary A; Tadros MI; Sakr TM
    Int J Pharm; 2020 Aug; 586():119514. PubMed ID: 32565281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotropic triphenylphosphonium doxorubicin-loaded core-shell nanoparticles for cellular and mitochondrial sequential targeting of breast cancer.
    Arafa KK; Smyth HDC; El-Sherbiny IM
    Int J Pharm; 2021 Sep; 606():120936. PubMed ID: 34310958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization.
    Ramasamy T; Tran TH; Cho HJ; Kim JH; Kim YI; Jeon JY; Choi HG; Yong CS; Kim JO
    Pharm Res; 2014 May; 31(5):1302-14. PubMed ID: 24297070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
    Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
    Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
    Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
    Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility studies of intravenously administered ionic-crosslinked chitosan-BSA nanoparticles as vehicles for antitumour drugs.
    Montero N; Pérez E; Benito M; Teijón C; Teijón JM; Olmo R; Blanco MD
    Int J Pharm; 2019 Jan; 554():337-351. PubMed ID: 30439492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interconnected hyaluronic acid derivative-based nanoparticles for anticancer drug delivery.
    Park JH; Cho HJ; Termsarasab U; Lee JY; Ko SH; Shim JS; Yoon IS; Kim DD
    Colloids Surf B Biointerfaces; 2014 Sep; 121():380-7. PubMed ID: 24993066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy
    Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang S
    Drug Deliv; 2020 Dec; 27(1):180-190. PubMed ID: 31924103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer.
    Lee R; Choi YJ; Jeong MS; Park YI; Motoyama K; Kim MW; Kwon SH; Choi JH
    Bioconjug Chem; 2020 Mar; 31(3):923-932. PubMed ID: 32027493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.